Laboratoire Aguettant
France - LyonBiotechnology
Focus: Laboratoire Aguettant is a France-based biotechnology company specializing in injectable formulations across infectious diseases, neurology, cardiovascular, women's health, and respiratory indications. The company operates as a focused injectable player with a mature product portfolio.
Profile data last refreshed 16h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Laboratoire Aguettant
AI assessmentNot HiringNo open roles listed right now. Follow Laboratoire Aguettant to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Laboratoire Aguettant's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Stable
Post-LOE
Core women's health asset; post-loss-of-exclusivity product generating sustained revenue through established market presence.
Help build intelligence for Laboratoire Aguettant
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.